the demonstrated single-dose activity of etoposide in hodgkin 's disease has prompted its inclusion in second-line programs , such as eva ( etoposide , vincristine or vinblastine , doxorubicin ) .
C0019829
hodgkin 's disease
C0042670
vinblastine